Aichelin, K. (2020). Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma. https://doi.org/10.11588/heidok.00022968
Chicago Style (17th ed.) CitationAichelin, Katharina. Development of a CD22-specific Chimeric Antigen Receptor (CAR) for the Adoptive T Cell Therapy of Leukemia and Lymphoma. Heidelberg, 2020. https://doi.org/10.11588/heidok.00022968.
MLA (9th ed.) CitationAichelin, Katharina. Development of a CD22-specific Chimeric Antigen Receptor (CAR) for the Adoptive T Cell Therapy of Leukemia and Lymphoma. 2020. https://doi.org/10.11588/heidok.00022968.
Warning: These citations may not always be 100% accurate.